Indicated for the management of the signs of mild, moderate or severe (modified NYHA Class IIa,IIb, IVc) congestive heart failure in dogs due to atrioventricular valvular insufficiency (AVVI) or dilated cardiomyopathy (DCM). Use with concurrent therapy for congestive heart failure (i.e. furosemide, etc) on a case by case basis.
Only FDA-approved veterinary inodilator (inotropie agent with vasodilatative properties), dilates both veins and arteries
Revision date indicates the date the MSDS or SDS was last revised. MSDS / SDS are
dated when they are originally issued AND when any significant change has been made
to the chemical compound or research has revealed a health or physical hazard different
from what was originally stated.